knowledge -WSS

knowledge

author：comprehensive 2025-09-27 22:36:53 Page View：94764

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Marvel Studios reveals new trailer for 'The Marvels': Watch here
Next article： After affirmative action ruling, medical educators look to 'holistic review'

explore

Apple is now the first public company to be valued at $3 trillion

6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

Elizabeth Warren probes abortion access

Sen.ElizabethWarren(D-Mass.)J.ScottApplewhite/APWASHINGTON—Sen.ElizabethWarren(D-Mass.)islaunchingaf

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

Marvel Studios reveals new trailer for 'The Marvels': Watch here

1:56BrieLarson,TeyonahParrisandImanVellaniinascenefrom"TheMarvels."MarvelStudiosMarvelStudioshasreve